Y. Tirefort

发表

Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome.

P. Guerne, Y. Chalandon, E. Roosnek, 2015, Joint, bone, spine : revue du rhumatisme.

Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm

R. D. Du Pasquier, P. Comoli, V. Dunet, 2020, Leukemia & lymphoma.

Mutation of the translation initiation codon in FGA causes congenital afibrinogenemia

P. de Moerloose, M. Neerman-Arbez, Y. Tirefort, 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

FLT3‐ITD mutations do not impact the outcome of patients allografted with partial T‐cell depleted grafts for AML with normal cytogenetics in first complete remission

C. Dantin, Y. Chalandon, E. Roosnek, 2017, Hematological oncology.

Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation

C. Dantin, A. Pradier, M. Ansari, 2018, Leukemia & lymphoma.

Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies

J. Passweg, A. Casini, T. Matthes, 2015, Bone marrow research.

Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants

M. Ansari, Y. Chalandon, E. Levrat, 2016, Bone Marrow Transplantation.

[Modalities for preparation, cryopreservation, thawing of hematopoietic stem cells and precautions for infusion to patient: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, M. Lacassagne, F. Pouthier, 2016, Bulletin du cancer.

A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia

C. Prins, T. Lecompte, T. Matthes, 2014, Biomarker Research.

Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.

C. Dantin, M. Ansari, A. Casini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

C. Dantin, A. Pradier, Y. Chalandon, 2019, Front. Immunol..

Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome

C. Dantin, A. Pradier, Y. Chalandon, 2018, Bone Marrow Transplantation.

Identification of a novel F11 missense mutation (Ile463Ser) in a family with congenital factor XI deficiency

M. Uhr, P. de Moerloose, M. Neerman-Arbez, 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index

C. Dantin, M. Ansari, Y. Chalandon, 2016, Bone Marrow Transplantation.

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

C. Dantin, M. Ansari, Y. Chalandon, 2016 .